James Lp

OverviewAI-generated summary

James Lp conducts research focused on the pharmacological effects and toxicity of substances, with a recent emphasis on drug threat analysis and population pharmacokinetics in infants. His work includes the validation of kits designed to automate liquid chromatography-tandem mass spectrometry (LC-MS/MS) analyses, contributing to the rapid identification and characterization of emerging drug threats. Lp also investigates population pharmacokinetic models for antibiotics like meropenem, specifically in infant populations, aiming to optimize treatment strategies. This research contributes to understanding drug behavior within specific demographic groups and improving analytical methods for toxicology.

Lp is a principal investigator on two federal grants from the National Institutes of Health (NIH), totaling over $4.4 million. These grants support the expansion of translational research and translational science initiatives within Arkansas. His collaborations include work with William E. Fantegrossi and Jeffery H. Moran at the University of Arkansas for Medical Sciences, evidenced by shared publications. With a h-index of 1 and 14 total citations across 4 publications, Lp is actively contributing to his fields.

Metrics

• h-index: 1
• Publications: 4
• Citations: 14